← FDA Drug Approvals (Drugs@FDA)

TACROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ENCUBE · Approved 2023-10-10

Drug application

FDA Application #
ANDA212387
Application type
Abbreviated New Drug Application (Generic)
Brand name
TACROLIMUS
Generic name
TACROLIMUS OINTMENT 0.1%
Active ingredients
TACROLIMUS
Dosage form
OINTMENT
Route
TOPICAL
Marketing status
Prescription
Sponsor
ENCUBE
Manufacturer
Encube Ethicals, Inc.
First approval
2023-10-10

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown